未治疗丙型肝炎感染与CKD患者肾功能下降的关联
这项回顾性队列研究纳入Kaiser Permanente南加州和中大西洋州成员中2004至2014年新诊断HCV和CKD的成人,比较未治疗HCV合并CKD与单纯CKD患者的eGFR下降速率及ESKD风险。结果显示,HCV合并CKD患者eGFR年下降多0.58 ml/min per 1.73 m2,eGFR下降25%和ESKD风险分别高1.87倍和1.93倍。
要点
- 未治疗HCV感染与CKD 3-5期患者eGFR下降更快相关。
- HCV合并CKD患者eGFR下降25%风险为单纯CKD的1.87倍。
- HCV合并CKD患者ESKD风险为单纯CKD的1.93倍。
核心结论
- 未治疗的HCV感染与CKD 3-5期患者肾功能下降更明显相关。
研究设计与样本
- 共纳入151974例单纯CKD患者和1603例HCV合并CKD患者。
- 采用广义估计方程比较eGFR变化率,Cox比例风险模型比较eGFR下降25%和ESKD风险,均调整协变量。
主要发现
- 调整后HCV合并CKD患者eGFR年下降较单纯CKD多0.58(95%CI 0.31至0.84)ml/min per 1.73 m2。
- HCV合并CKD患者eGFR年变化为-1.61(95%CI -1.87至-1.35)ml/min,单纯CKD为-1.04(95%CI -1.06至-1.01)ml/min。
- 调整协变量后,HCV合并CKD患者eGFR下降25%的风险比为1.87(95%CI 1.75至2.00)。
- 调整协变量后,HCV合并CKD患者ESKD的风险比为1.93(95%CI 1.64至2.27)。
关键数值与推荐
- ESKD定义为两次或以上、至少间隔90天eGFR<15 ml/min per 1.73 m2。
临床怎么用
- 对CKD 3-5期合并未治疗HCV感染的患者,应关注肾功能下降加速风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Studies evaluating the role of hepatitis C viral (HCV) infection on the progression of CKD are few and conflicting. Therefore, we evaluated the association of untreated HCV on kidney function decline in patients with stage 3-5 CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study included members of Kaiser Permanente Southern California and Kaiser Permanente Mid-Atlantic States aged ≥18 years, with incident HCV and CKD diagnoses from January 1, 2004 to December 31, 2014. We used generalized estimating equations to compare the rate of change in eGFR between those with HCV and CKD versus CKD alone, adjusting for covariates. Cox proportional hazards models compared the risk of 25% decrease in eGFR and ESKD (defined as progression to eGFR<15 ml/min per 1.73 m2 on two or more occasions, at least 90 days apart) in those with HCV and CKD versus CKD alone, adjusting for covariates. RESULTS: We identified 151,974 patients with CKD only and 1603 patients with HCV and CKD who met the study criteria. The adjusted annual decline of eGFR among patients with HCV and CKD was greater by 0.58 (95% confidence interval [95% CI], 0.31 to 0.84) ml/min per 1.73 m2, compared with that in the CKD-only population (HCV and CKD, -1.61; 95% CI, -1.87 to -1.35 ml/min; CKD only, -1.04; 95% CI, -1.06 to -1.01 ml/min). Adjusted for covariates, the hazard for a 25% decline in eGFR and for ESKD were 1.87 (95% CI, 1.75 to 2.00) and 1.93 (95% CI, 1.64 to 2.27) times higher among those with HCV and CKD, respectively, compared with those with CKD only. CONCLUSIONS: Untreated HCV infection was associated with greater kidney function decline in patients with stage 3-5 CKD.
引用
- Tartof SY, Hsu JW, Wei R, et al. Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection. Clin J Am Soc Nephrol. 2018. PMID: 30242027. doi:10.2215/CJN.01530218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。